UCSF
Neurology Clinical Programs
Multiple Sclerosis
Help us fund research
that is changing lives

Donate
Let us know about
a "star" employee:

Thanks Program

Studies and Trials

The UCSF MS Research Center is conducting the following experimental studies:

Clinical Trials of Disease Modifying Treatments

Open to enrollment for patients with relapsing multiple sclerosis

    CHORD Study - An open-label study to evaluate the efficacy and safety of Ocrelizumab in patients with relapsing remitting multiple sclerosis (MS) who had suboptimal response to other MS treatment
    RADIANCE Study - A randomized study to evaluate the efficacy and safety of RPC1063
    Vitamin D - RCT Study - A randomized controlled trial of vitamin D in multiple sclerosis

Open to enrollment for patients with progressive multiple sclerosis

    NAC Pilot Study - A randomized study to evaluate the efficacy of N-acetyl cysteine on fatigue in patients with progressive multiple sclerosis

Open to enrollment for patients with optic neuritis

    ReCOVER - A randomized controlled trial of Clemastine Fumarate as a remyelinating agent in acute optic neuritis

Interventional Trials

    IQooL My MS - Improving Quality of Life in Menopausal women with Multiple Sclerosis

Observational Studies

Open to enrollment for MS patients

    EPIC Study
    ORIGINS Study - Discovering the triggers of MS
    iMSMS - Microbiome Research in MS
    MYO Study - A sub study of TRAC MS
    Digital Cognition Study - Brain Re-Training in Multiple Sclerosis
    Visual Evoked Poternials (VEP) in the evaluation of Neurological Disease
    Neuroimmunology Banking Studies - The collection and banking of samples for studies to understand molecular and cellular immunological mechanisms in MS.
    Genetic Susceptibility to Develop MS

Open to enrollment for patients with neuromyelitis optica or neurosarcoidosis

    Neuromyelitis Optica - T Cell Recognition of CNS Autoantigens in Multiple Sclerosis and Neuromyelitis Optica
    Neuroimmunology Banking Studies - The collection and banking of samples for studies to understand mechanisms of B cell immunology in NMO.

Ongoing studies that are closed to enrollment

    OPERA - Study to evaluate the efficacy and safety of Ocrelizumab in comparison to Interferon Beta-1a (Rebif®) in patients with Relapsing Multiple Sclerosis
    ORATORIO - Study to evaluate the efficacy and safety of Ocrelizumab in adults with Primary Progressive Multiple Sclerosis.
    ReBUILD - A randomized trial to assess an identified molecule as a remyelinating agent in Multiple Sclerosis
    PREFERMSStudy - A randomized, open-label study to evaluate the patient retention of Fingolimod.
    Sarcoid - Neurological manifestations of Sarcoidosis and ways to distinguish Sarcoidosis from other causes of nervous system Inflammation